These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 17402836)

  • 1. A new era in HIV vaccine development.
    Lau CY; Velasco PP; Johnston MI
    Expert Rev Anti Infect Ther; 2007 Apr; 5(2):205-15. PubMed ID: 17402836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Future paths for HIV vaccine research: Exploiting results from recent clinical trials and current scientific advances.
    Bansal GP; Malaspina A; Flores J
    Curr Opin Mol Ther; 2010 Feb; 12(1):39-46. PubMed ID: 20140815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV vaccine development: the myth of Sisyphus modernized?
    Ljungberg K
    Expert Rev Vaccines; 2007 Dec; 6(6):879-82. PubMed ID: 18377348
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of therapeutic vaccines in the control of HIV-1.
    Kinloch-de Loes S
    J Antimicrob Chemother; 2004 Apr; 53(4):562-6. PubMed ID: 14985273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AIDSVAX VaxGen.
    Billich A
    Curr Opin Investig Drugs; 2004 Feb; 5(2):214-21. PubMed ID: 15043397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The International AIDS Vaccine Initiative.
    Berkley S
    J Int Assoc Physicians AIDS Care; 1997 Nov; 3(11):30-4. PubMed ID: 11364811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV vaccine research in Thailand: lessons learned.
    Pitisuttithum P
    Expert Rev Vaccines; 2008 Apr; 7(3):311-7. PubMed ID: 18393601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AIDS vaccine: efficacy, safety and ethics.
    Veljkovic V; Veljkovic N; Glisic S; Ho MW
    Vaccine; 2008 Jun; 26(24):3072-7. PubMed ID: 18164521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV vaccine development: past, present and future.
    Robb ML
    IDrugs; 2010 Dec; 13(12):852-6. PubMed ID: 21154142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The challenges of HIV vaccine development and testing.
    Burgers WA; Williamson C
    Best Pract Res Clin Obstet Gynaecol; 2005 Apr; 19(2):277-91. PubMed ID: 15778116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An HIV/AIDS vaccine: where do we go from here?
    Bernstein A
    Trends Microbiol; 2008 Dec; 16(12):553-4. PubMed ID: 18964019
    [No Abstract]   [Full Text] [Related]  

  • 12. Medicine. The need for a global HIV vaccine enterprise.
    Klausner RD; Fauci AS; Corey L; Nabel GJ; Gayle H; Berkley S; Haynes BF; Baltimore D; Collins C; Douglas RG; Esparza J; Francis DP; Ganguly NK; Gerberding JL; Johnston MI; Kazatchkine MD; McMichael AJ; Makgoba MW; Pantaleo G; Piot P; Shao Y; Tramont E; Varmus H; Wasserheit JN
    Science; 2003 Jun; 300(5628):2036-9. PubMed ID: 12829768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonstructural HIV proteins as targets for prophylactic or therapeutic vaccines.
    Ferrantelli F; Cafaro A; Ensoli B
    Curr Opin Biotechnol; 2004 Dec; 15(6):543-56. PubMed ID: 15560981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Broadening inclusion of vulnerable populations in HIV vaccine trials.
    Lau CY; Cardinali M; Sato PA; Fix A; Flores J
    Expert Rev Vaccines; 2008 Mar; 7(2):259-68. PubMed ID: 18324894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 25 years of HIV research! ... and what about a vaccine?
    Appay V
    Eur J Immunol; 2009 Aug; 39(8):1999-2003. PubMed ID: 19672891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AlphaVax receives NIAID contract to support development of HIV vaccine.
    Expert Rev Vaccines; 2003 Dec; 2(6):731-2. PubMed ID: 15282844
    [No Abstract]   [Full Text] [Related]  

  • 17. Cold shower for AIDS vaccines.
    Nat Med; 2007 Dec; 13(12):1389-90. PubMed ID: 18064013
    [No Abstract]   [Full Text] [Related]  

  • 18. The elusive HIV vaccine: an update on the politics, propaganda and scientific barriers in the search for a safe and effective HIV vaccine.
    Allen D
    Posit Aware; 1999; 10(4):30-4, 37. PubMed ID: 11366804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Executive summary and recommendations from the WHO/UNAIDS/IAVI expert group consultation on 'Phase IIB-TOC trials as a novel strategy for evaluation of preventive HIV vaccines', 31 January-2 February 2006, IAVI, New York, USA.
    WHO/UNAIDS/IAVI International Expert Group
    AIDS; 2007 Feb; 21(4):539-46. PubMed ID: 17301582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AIDS vaccine development and challenge viruses: getting real.
    Vlasak J; Ruprecht RM
    AIDS; 2006 Nov; 20(17):2135-40. PubMed ID: 17086052
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.